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ABSTRACT
Dental decay is one of the most prevalent chronic and infectious diseases for mankind. It is defined as “a dy-
namic process, taking place in the tooth bacterial biofilm (plaque), which results in a disturbance of equi-
librium between tooth substance and the surrounding plaque fluid and finally results in a loss of minerals 
from the tooth surface - demineralisation.” Fluoride plays an important role in dental decay prevention and 
stimulates self-healing of minor cavities by reducing the demineralisation process and promoting the rem-
ineralisation process. Remineralisation occurs frequently, especially when the biofilm pH is restored by sa-
liva, which acts as a buffer. The adequate salivary production is of great importance for maintaining a nor-
mal physiology in the oral cavity.
It is known that children with congenital heart disease (CHD) frequently require regular long-term medi-
cation, but the knowledge of oral health effects caused by long-term medication in medically compromised 
children is sparse. Many medications used on a long-term basis may contain sugar, have a low pH or high 
acidity. There is a strong correlation between xerostomia and pharmacological treatment and a number of 
drugs have been listed as xerogenic. These drugs include ones with a directly damaging to salivary glands 
function, such as cytotoxic drugs, medications with anticholinergic activity, drugs which deplete fluid as di-
uretics, and drugs acting on the sympathetic system, like antihypertensive drugs. Only a few clinical stud-
ies have been carried out on the outcome of salivary function with antihypertensive drugs, and the outcome 
is not clear-cut.
A number of studies have been carried out on the caries prevalence in children with CHD but only five of 
them were controlled. Children with CHD had higher mean values of dmft /DMFT indices than healthy chil-
dren and only a few of them had experienced fillings, indicating an unmet need for operative treatment.
Keywords: congenital heart disease (CHD), dental decay, periodontal disease, children, risk factors, 
medication
Saliva as a Risk Factor for Dental Decay and/
or Periodontal Diseases Formation
The adequate saliva formation is of great im-
portance for the normal physiology of oral cavity. 
Saliva is being produced by the three major pairs of 
salivary glands – parotid, submandibular and sub-
lingual, and by many more minor ones – labial, buc-
cal, lingual and palatal glands, in an overall volume 
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of 0.5-1.0 L per day.  Normally, salivary glands should 
be fully developed around 15 years of age,  salivary 
flow should increase with age and girls should have 
lower levels of saliva secretion than boys the same age 
(1-4). Saliva, produced by different salivary glands, 
has a typical and different composition, which var-
ies within a 24-hour period (1-5). The composition 
of saliva may change under the influence of different 
stimuli, as well (1, 6). Saliva contains inorganic ions, 
such as calcium and phosphates, and organic com-
pounds like proteins, carbohydrates, immunoglob-
ulins, and enzymes. In the oral cavity, the product 
of salivary glands is being mixed with the secretion 
from the nasal cavity and pharyngeal space, epithe-
lium cells and millions of microorganisms, and the 
overall product is referred in specialised literature as 
whole saliva (1,5). 
Saliva plays an important role in the complex 
oral ecosystem. Many crucial for the health of the 
oral cavity factors may be found among its com-
pounds (1,7). One of the most important functions 
of saliva is to neutralise the acids, produced in den-
tal plaque. This means that reduced salivary flow au-
tomatically puts the patient in higher risk for dental 
decay and/or periodontal disease formation. Saliva 
has a lubricating effect over all oral tissues and thus 
facilitates the processes of mastication, swallowing 
and speech. Saliva takes part in the initial stages of 
food digestion, too (1, 5, 8). Through its buffering ca-
pacity, saliva protects the oral cavity from damaging 
variations of pH values. By means of some of its an-
timicrobial agents, such as immunoglobulins, saliva 
stands as a barrier against bacteria and viruses, pre-
venting their entrance through the oral mucosa. Its 
composition includes IgG, IgM and IgA, but main-
ly secretory IgA (sIgA) (1,9). sIgA is mainly produced 
by plasmatic cells, located in connective tissue, and 
is being transferred to the excretory canals of ma-
jor and minor salivary glands (1,3,10). sIgA against 
Streptococcus mutans (SM) may be found in saliva 
samples from the majority of children over 3 years 
of age and the quantity of these  antibodies increas-
es proportionately with the time of exposition (9, 11).
Salivary glands show dual innervation from 
both sympathetic and parasympathetic nervous sys-
tems. Stimulating the parasympathetic system in-
creases salivary flow, while sympathetic stimulation 
causes the production of scarce but more viscous sali-
va (1, 5). Pharmacotherapy is the most common rea-
son for damaged salivary secretion (3,5,8).
Dental Decay
Dental decay is the most prevalent chronic be-
havioural infectious disease for mankind. The risk 
for dental decay occurrence is present during a life-
time. Dental caries is the main reason for pain in the 
oral cavity region and for the loss of teeth from both 
primary and permanent dentition (12).
Dental decay is known to be a dynamic dis-
ease, which takes place on a specific surface, due to 
damaged physiological balance between minerals in 
hard dental tissues on one side, and the liquid phase 
of plaque, on the other, resulting in de- or reminer-
alisation processes (5,12,13). Demineralisation, due 
to dental decay, is a process of plaque-induced deg-
radation of minerals (calcium and phosphates) from 
the hard dental tissues. Remineralisation is defined 
as net weight gain of mineral ions in hard dental tis-
sues. The new mineral ions take the place of the ions, 
lost during the previous demineralisation (12-14).
The carious lesion may be reversed if regis-
tered and stopped in early stages of formation, but if 
left untreated, it may destroy the whole crown of the 
tooth (15). A great number of clinical studies show 
close correlation between dental decay, being present 
in primary dentition, and its further presence in per-
manent dentition (16-19). One of the main aims in 
pediatric dentistry consists of the struggle to prevent 
dental decay formation in primary dentition (1). 
Pathogenesis of Dental Decay
The carious lesion forms under the influence 
of interacting acidogenic bacteria, such as SM and 
Lactobacilli (LBC), sugar from food, which bacteria 
metabolise, and a few variable intrinsic and extrin-
sic factors (1, 15, 20). The most cariogenic bacterial 
group in the oral cavity is presented by SM (1, 21). In-
creasing in the overall portion of acidogenic bacte-
ria, such as SM and LBC, in the composition of den-
tal plaque is connected with the formation of den-
tal decay lesions (22). Changes in the composition of 
plaque, which promote acidogenic species, take place 
due to changes in the surrounding environmental 
conditions. Examples for such changes may be re-
duced salivary secretion, regular sufficient intake of 
sugar, poor oral hygiene or different combinations of 
the listed factors (23-26). The low pH values, gener-
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ated by the produced acids, change the dynamic ho-
meostasis in microbial ecosystem, causing the future 
natural selection of more acidogenic and acid-toler-
ant microbial species. The acids, produced by acido-
genic bacteria, will cause demineralisation and low-
ering of pH levels below the critical one (5.5), under 
which no remineralisation processes can take place 
(27). If demineralisation processes continue, the sur-
face of the tooth will soon show signs of cavitation. 
On the other hand, if minerals in the saliva, such as 
fluoride, calcium or phosphate, diffuse into the tooth 
structure under specific conditions, remineralisa-
tion may take place. The remineralised region of the 
tooth structure is usually more acid-resistant than 
the restored one. Remineralisation normally takes 
place all the time if the saliva function is unaffected 
and thus its buffering systems can properly regulate 
the acidity in dental plaque (27).
Epidemiology of Dental Decay among Chil-
dren with Congenital Heart Disease (CHD)
A number of studies show results, concerning 
the prevalence of dental decay among Swedish chil-
dren. Two of them, carried out in 2006 and 2007, 
show that 6-7% of children at the age of 2 are affected 
by dental caries (28,29). There is a registered decrease 
in dental decay prevalence among Swedish children 
(30, 31), but dental decay still stays a frequently en-
countered diagnosis in primary dentition (32). 
Many chronic diseases in childhood are corre-
lated to poor oral health (33). Out of a great num-
ber of studies, concerning dental decay prevalence 
among children with CHD (34-40), only five were 
Table 1. Published study results on dental decay prevalence among children with CHD 
Author, Year Country Number of patients Age Decay/Age group
Berger, 1978 (35) Australia CHD = 57Ctr = 57 8-10
Cyanotic CHD had higher Dt, DT 
and MT.




1.6    0.8       10%
3    1.4           2%
Rai et al., 2009 (38) India CHD = 170 1-16 42% affected by tooth decay.
Balmer & BuLock, 2003 
(34) UK
Children in higher risk 
from IE = 38 2-16 39% with untreated decay lesions.
Pollard & Curzon, 1992 
(4) UK
CHD =100
Ctr = 100 2-16
2-4 dmft=1,8/ 1.6 Ctr    
5-9 DMFT=4.3/ 2.8 Ctr 
10-16 DMFT=10.6/ 0.5 Ctr
Franco et al., 1996 (36) UK CHD= 60Ctr = 60 2-16
dmft     DMFT
3.7       2.7-3.4
3.2       2-2.9
 
Untreated decay:
CHD = 52% 
Ctr = 32%
Da Silva et al., 2002 (6) Brazil Children in higher risk from IE = 38IE = 104 2-17
dmft  2.6 ± 3.0 
DMFT 4.0 ± 4.1  




dmft      DMFT
4.2          0.9
2.3          0.6
Hayes & Fasules, 2001 
(43) USA
Children, planned for 
cardiac surgery = 209
> 6 
months 29% were affected by dental decay.
Urquhart & Blinkhorn, 
1990 (40) UK CHD = 134 4-12
4-6   dmft = 3.3      
7-9 DMFT = 3.5
10-12 DMFT=5 
Teodora Nikolova, Radosveta Andreeva, Milena Georgieva et al.
Scripta Scientifica Medicinae Dentalis, 2017;3(2):48-55
Medical University of Varna
51
actually controlled studies (35,36,37,38,39). The pub-
lished results, concerning caries prevalence among 
children with CHD, are listed in Table 1.  In these 
clinical trials, published between 1978 and 2008, the 
gravity of CHD and the way of managing results dif-
fer, but they all register a greater number of untreat-
ed decays, greater treatment needs and higher den-
tal decay prevalence among the CHD patients, com-
pared to healthy children.
The prevalence of dental decay among children 
is thoroughly examined and it is proven that chil-
dren with migrant origin (32) and medically com-
promised children (17,41,42,43), show higher dmft/
DMFT indices, compared to healthy children. There 
is still not enough information, concerning dental 
decay prevalence among the continuously enlarging 
group of children with CHD. 
Oral Effects of Pharmacotherapy
It is known that children with CHD frequent-
ly require regular long-term medication (44), but the 
knowledge of oral health effects, caused by long-term 
medication in medically compromised children, is 
sparse (45). Many of the pharmaceutical prepara-
tions, prescribed for long-term treatment, have high 
acidity and contain sugar (46, 47). The strong cor-
relation between xerostomy and pharmacological 
treatment is a fact (48), and many medications are 
listed as xerogenic (49). These pharmaceutic prepa-
rations include such with direct damaging effect on 
salivary glands as cytotoxic drugs, medications with 
anticholinergic effect, diuretics and antihypertensive 
preparations, which affect the sympathetic nervous 
system (50). Only a few clinical trials had registered 
if there is a damaged salivary secretion in patients on 
long-term antihypertensive medication, but the re-
sults were not clear cut (51). The effect of Р-adreno-
receptor antagonists atenolol and propranolol on sal-
ivary flow and composition was examined in healthy 
men and the results registered no decrease of salivary 
flow, but lower values of overall saliva protein (52). 
Patients with hypertonia increase their salivary flow 
during withdrawal of the P1-selective medication 
metoprolol (53). Treatment with ACE-inhibitor cap-
topril increases the speed of secretion of non-stim-
ulated and stimulated by chewing of paraffin whole 
saliva. It also increases the salivary flow from the pa-
rotid gland. No deviations from normal saliva com-
position were observed (54). Thiazide diuretics are 
proven to diminish salivary secretion in 34 healthy 
adult volunteers (55).  
For the purpose of maintaining chemical stabil-
ity, tonicity and physiological compatibility of medi-
cations, acids are being used as buffering compounds 
(45). Fermentable carbohydrates, such as sucrose, 
may be added to pediatric preparations for making 
them taste better and thus facilitate the intake.  Sug-
ar, added to the composition of the pharmaceutical 
preparations, causes diminishing of the pH values in 
plaque, due to their quick metabolisation to acids by 
the microorganisms (33). On the other hand, acids 
in the composition prevent the pH levels from get-
ting back to normal for a long time after sugar in-
take. Thus, apart from its effect on salivary secre-
tion, pharmaceutical therapy may have direct dam-
aging effect on oral health by mediating decay and/
or erosion formation (47,49,56,57). Dental erosion is 
multifactorial disease, defined as “aseptic” or non-
carious dissolution of the mineral phase of the tooth 
from acids, when the surrounding liquid phase lacks 
these minerals (58). The mineral phase of hard dental 
tissues is represented mainly by calcium and phos-
phates, organised most commonly in hydroxyapatite 
crystals, with critical value of pH around 5.5 (58). Ev-
ery matter with lower pH is capable of causing dis-
solving of hard dental tissue, leading to either den-
tal decay or dental erosion (59). The etiology behind 
dental erosion is usually classified as having extrinsic 
or intrinsic causes. Long-term medication and reg-
ular intake of sour foods are the most common ex-
trinsic factors. The intrinsic factors include some dis-
eases and/or their consequences (60). For example, in 
patients with gastro-esophageal reflux, the stomach 
acids reach oral cavity and cause a typical clinical 
picture of generalised dental erosions (60).
Prevention of Dental Decay Formation among 
Children with CHD
The concept of early prevention lies on the the-
sis that primary teeth are usually sound when erupt-
ing and dental health during pre-school period is im-
portant, because it reflects the dental status of future 
mixed and permanent dentition, as well (16-19). The 
increased levels of oral health indices after 1970 are 
due to the early introduced informational meetings 
for parents, concerning oral health of their children, 
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and also due to the higher extent of fluoride usage for 
the means of dental decay prophylaxis (29). 
There are few mechanisms, through which flu-
orides imply their cariostatic effect. They include de-
crease of demineralisation, stimulation of reminer-
alisation processes, influence over the formation and 
composition of dental pellicle and plaque, suppres-
sion of microbial growth and metabolism (34, 61-65). 
Small quantities of fluoride in saliva diminish the 
solubility of the mineral phase of hard dental tissues. 
Fluoride ions, incorporated into the mineral phase, 
cause the formation of a thin layer of fluorapatite 
crystals, and they are known for having higher levels 
of critical pH than hydroxyapatite. Fluoride may hin-
der bacterial metabolism by inhibiting the enolase 
enzyme and thus the synthesis of glucans by SM is 
disturbed (34, 66-69). All these mechanisms change 
the balance between de- and remineralisation in fa-
vour of remineralisation (34,67,70). 
The strong caries-protective effect of fluoride 
ions in acidified environment is due to the hydroflu-
oric acid formation and its rapid penetration through 
bacterial membranes (71,72). Inside the cellular cyto-
plasm this acid may dissociate into fluoride and hy-
drogen ions again. The fluoride ion interferes with 
bacterial enolase and adenosintriphosphatase and 
thus hinders bacterial metabolism (70,71). The free 
hydrogen ion may cause acidification of the cyto-
plasm, which is fatal for the enzymes of the glycolytic 
process of fermentation (71,73).
The effect of fluoride prophylaxis strongly cor-
relates with the frequency of its application. Fluoride, 
included in everyday toothpastes, is believed to be 
the most effective form of individual exogenous flu-
oride prophylaxis at home (63), while the profession-
al fluoride application of fluoride varnishes at the 
dental office on a six-month periods is the most ef-
ficient professional method for small children with 
a high risk for dental decay formation (74). For chil-
dren with specific healthcare needs the regular dai-
ly endogenous intake of fluoride is of great impor-
tance. Both forms of endogenous fluoride prophy-
laxis – tablets and solutions, are told to prevent ear-
ly childhood caries (ЕСС) among children with lip 
and/or cleft palates (75). In many countries, the main 
form of dental decay prophylaxis for healthy indi-
viduals consists of brushing with fluoride toothpaste 
twice a day. For some medically compromised pa-
tients, who are at higher risk for dental decay forma-
tion (33,41,42,76), additional endogenous intake is 
indicated, after the precise dosage is adapted in ac-
cordance with personal needs and the level of com-
pliance of the child and its parents (77).
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